Immatics Share Price

Immatics Share Price

NASDAQ: IMTX | Healthcare
$6.14
-$0.14 (-2.15%) Last updated on 19 Nov, 2026 | 01:23 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Immatics Stock Performance

Open
$6.39
Prev. Close
$6.28
Circuit Range
N/A
Day Range
$6.07 - $6.39
Year Range
$6.07 - $12.41
Volume
53,752
Average Traded
$6.18

Immatics Share Price Today

As of 19 November 2026, Immatics N.V.'s share price is $6.14. The stock opened at $6.39, compared to its previous close of $6.28. During today's trading session, Immatics N.V.'s share price traded between $6.07 and $6.39, with an average price of $6.23. Over the past 52 weeks, the stock has recorded a high of $12.41 and a low of $6.07. In terms of performance, Immatics N.V.'s share price has declined by 46.68% over the last six months and is down 43.33% on a year-on-year basis.

Immatics Share Price Chart

Line chart of the Immatics price trend over the selected period. The price fell overall, ranging from 6.08 to 6.39, ending at 6.14.
$6.07$6.39
L
Show Current Price
H

Immatics Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$56.63B
Return On Equity (TTM)
N/A
Profit Margin
-406.99%
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Immatics Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$185.39$59.69$162.16$56.63
Net Profit$29.72-$104.63$15.84-$230.48
Net Profit Margin16.03%-175.29%9.77%-406.99%
Income ChangeN/A-452.05%115.14%-1555.05%

Immatics Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets68.4469.2966.9932.89
Current Assets591.34655.09496.76404.56
Total Assets659.77724.39563.74437.46
Non Current Liabilities41.3355.48150.12105.14
Current Liabilities50.4670.74173.06114.19
Total Liabilities91.79126.22323.18219.33
Shareholders' Equity567.98598.16240.57218.13

Immatics Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-207.23-164.4420.15107.41
Investing240.27-158.57-34.7-225.04
Financing114.22332.6593.43132.7

About Immatics

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Immatics Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$7.22
$6.12
-14.82%
Oct 2026
$8.72
$7.18
-18.07%
Sep 2026
$9.43
$8.77
-6.20%
Aug 2026
$8.48
$9.35
+7.97%
Jul 2026
$9.87
$8.66
-14.30%
Jun 2026
$11.55
$10.11
-12.24%
May 2026
$11.22
$11.52
+4.87%
Apr 2026
$9.96
$10.98
+11.70%
Mar 2026
$10.37
$9.83
-5.34%
Feb 2026
$9.53
$10.38
+9.09%
Jan 2026
$10.51
$9.52
-9.33%
Dec 2025
$10.47
$10.50
-3.09%

Immatics Share Price FAQs